Engineered enzyme for enzyme replacement therapy
Updated time: 2021-12-07 12:04:01
Engineered enzyme for enzyme replacement therapy
Docket Number
12A-1040216
IP Status
TW I617573、US 10604747 B2
Abstract
This technology can decrease the immunogenicity of therapeutic enzymes.
Technological Advantages
This approach can decrease the inherent immunogenicity of therapeutic enzymes. This may be especially beneficial for gene therapy or enzyme replacement therapy in patients that react to the administered enzyme or gene product.
Applications of Technology
- Enzyme replacement therapy
- Gene therapy
Inventor
Steve Roffler, Huai-Yao Chuang
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office
Download Files

Engineered enzyme for enzyme replacement therapy